Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
| Image |  |
|---|---|
| Description | scientific article published on 16 August 2019 |
| Author/s |
author: Hans-Christoph Diener |
| Publication date | August 16, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |